All Stories

  1. Don’t let the perfect be the enemy of the good
  2. Has GWAS lost its status as a paragon of open science?
  3. State Anxiety and Alcohol Choice: Evidence from Experimental and Online Observational Studies
  4. The Outfit Choice Task as a novel method for measuring body dissatisfaction in women with eating disorders and healthy controls
  5. The development and validation of a human screening model of tobacco abstinence
  6. Long-term effectiveness and safety of varenicline and nicotine replacement therapy in people with neurodevelopmental disorders: A prospective cohort study
  7. Research Culture and Reproducibility
  8. Cohort profile for the STratifying Resilience and Depression Longitudinally (STRADL) study: A depression-focused investigation of Generation Scotland, using detailed clinical, cognitive, and neuroimaging assessments
  9. The impact on selection of non-alcoholic vs alcoholic drink availability: an online experiment
  10. Alcohol use in late adolescence and early adulthood: The role of generalized anxiety disorder and drinking to cope motives
  11. Mendelian randomisation for nutritional psychiatry
  12. MR-pheWAS with stratification and interaction: Searching for the causal effects of smoking heaviness identified an effect on facial aging
  13. Tobacco and electronic cigarette cues for smoking and vaping: an online experimental study
  14. Does e-cigarette use in non-smoking young adults act as a gateway to smoking? A systematic review and meta-analysis
  15. The Causal Effects of Health Conditions and Risk Factors on Social and Socioeconomic Outcomes: Mendelian Randomization in UK Biobank
  16. Policies for Tobacco and E-Cigarette Use: A Survey of All Higher Education Institutions and NHS Trusts in England
  17. Variation in recognition of happy and sad facial expressions and self-reported depressive symptom severity: A prospective cohort study
  18. Avoidance of tobacco health warnings? An eye-tracking approach
  19. Investigating the added value of biomarkers compared with self-reported smoking in predicting future e-cigarette use: Evidence from a longitudinal UK cohort study
  20. Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study
  21. Impact of health warning labels on snack selection: an online experimental study
  22. Alcohol use and cognitive functioning in young adults: an observational and Mendelian randomisation study
  23. Facial affect recognition in adolescent and young adult offenders with and without traumatic brain injury
  24. Should cigarette pack sizes be capped?
  25. Effect of nucleation on the likeability and drinking rate of lager in social alcohol drinkers
  26. Impact of health warning labels on alcohol selection: An online experimental study
  27. E‐cigarette research needs to adopt open science practices to improve quality
  28. Use of varenicline and nicotine replacement therapy in people with and without general practitioner-recorded dementia: retrospective cohort study of routine electronic medical records
  29. Availability of public databases for triangulation of findings
  30. A Phenome-Wide Mendelian Randomization Study of Pancreatic Cancer Using Summary Genetic Data
  31. Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes
  32. Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders
  33. Mendelian randomisation analysis of the effect of educational attainment and cognitive ability on smoking behaviour
  34. Comment on the Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank
  35. Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study
  36. Commentary on Gorman (2019): Publication procedures are only part of the solution
  37. Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability
  38. Understanding the consequences of education inequality on cardiovascular disease: mendelian randomisation study
  39. Policies for tobacco and e-cigarette use: a survey of all higher education institutions and NHS Trusts in England
  40. Should cigarette pack sizes be capped?
  41. The effect of smoking intensity on all-cause and cause-specific mortality—a Mendelian randomization analysis
  42. Is useful research data usually shared? An investigation of genome-wide association study summary statistics
  43. The prevalence of left-handedness: Five meta-analyses of 200 studies totaling 2,396,170 individuals
  44. Effect of nucleation on the likeability and drinking rate of lager in social alcohol drinkers
  45. Have e-cigarettes renormalised or displaced youth smoking? Results of a segmented regression analysis of repeated cross sectional survey data in England, Scotland and Wales
  46. Prenatal alcohol exposure and offspring mental health: A systematic review
  47. Schizophrenia risk and reproductive success: a Mendelian randomization study
  48. Small Sample Sizes and a False Economy for Psychiatric Clinical Trials
  49. Locus of control is associated with tobacco and alcohol consumption in young adults of the Avon Longitudinal Study of Parents and Children
  50. Associations of child and adolescent anxiety with later alcohol use and disorders: a systematic review and meta‐analysis of prospective cohort studies
  51. Improving the Transparency and Robustness of Research
  52. Conditioning on a Collider May Induce Spurious Associations: Do the Results of Gale et al. (2017) Support a Health-Protective Effect of Neuroticism in Population Subgroups?
  53. Effects of acute alcohol consumption on emotion recognition in social alcohol drinkers
  54. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
  55. IntEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): protocol for a randomised and controlled, multicentre, acceptability, feasibility and implementation trial
  56. Smoking and the risk for bipolar disorder: causal evidence from a bidirectional Mendelian randomization study
  57. Is screen time associated with anxiety or depression in young people? Results from a UK birth cohort
  58. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use
  59. Does smoking cause poor mental health?
  60. The effect of body mass index on smoking behaviour and nicotine metabolism: a Mendelian randomization study
  61. Alcohol pictorial health warning labels: the impact of self-affirmation and health warning severity
  62. Maternal smoking during pregnancy and autism: using causal inference methods in a birth cohort study
  63. A double-blind, randomized, placebo-controlled trial of a computer-based Interpretation Bias Training for youth with severe irritability: a study protocol
  64. Informing drinkers: Can current UK alcohol labels be improved?
  65. Association of alcohol consumption with allergic disease and asthma: a multi-centre Mendelian randomization analysis
  66. Evidence for Genetic Correlations and Bidirectional, Causal Effects Between Smoking and Sleep Behaviors
  67. Cigarette smoking and personality: interrogating causality using Mendelian randomisation
  68. Effect of glass shape on the pouring accuracy of liquid volume
  69. Training in experimental design and statistics is essential: Response to Jordan
  70. Open science prevents mindless science
  71. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study
  72. Investigating the impact of cigarette smoking behaviours on DNA methylation patterns in adolescence
  73. Investigating possible causal effects of externalizing behaviors on tobacco initiation: A Mendelian randomization analysis
  74. A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response
  75. Evaluation of the causal effects between subjective wellbeing and cardiometabolic health: mendelian randomisation study
  76. Mediators of the effect of nicotine pre-treatment on quitting smoking
  77. Swap outdated authorship listings for contributorship credit
  78. A systematic review of the next-day effects of heavy alcohol consumption on cognitive performance
  79. GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia
  80. Genome-wide association meta-analysis of age at first cannabis use
  81. The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: the case of depression
  82. Nicotine preloading for smoking cessation: the Preloading RCT
  83. Commentary on Kristjansson et al . (2018): Caffeine use during early adolescence as a possible risk factor for initiation of smoking and alcohol use
  84. Investigating causality in associations between education and smoking: a two-sample Mendelian randomization study
  85. Are e-cigarettes tobacco products?
  86. Effects on abstinence of nicotine patch treatment before quitting smoking: parallel, two arm, pragmatic randomised trial
  87. Nicotine & Tobacco Research is Moving to Online-Only Publication
  88. Science is a Marathon Not a Sprint: Creating a Positive Culture for Early Career Researchers
  89. What about treatment of smoking to improve survival and reduce depression?
  90. Intrauterine alcohol exposure and offspring mental health: A systematic review
  91. Exploring the association of genetic factors with participation in the Avon Longitudinal Study of Parents and Children
  92. Habitual coffee consumption and cognitive function: a Mendelian randomization meta-analysis in up to 415,530 participants
  93. Effects of exposure to bodies of different sizes on perception of and satisfaction with own body size: two randomized studies
  94. An investigation of emotion recognition training to reduce symptoms of social anxiety in adolescence
  95. Nudging transparent behavioural science and policy
  96. Investigating genetic correlations and causal effects between caffeine consumption and sleep behaviours
  97. Severity and susceptibility: measuring the perceived effectiveness and believability of tobacco health warnings
  98. Ultradian rhythmicity of plasma cortisol is necessary for normal emotional and cognitive responses in man
  99. What exactly is ‘N’ in cell culture and animal experiments?
  100. Using Neuroscience to Inform Tobacco Control Policy
  101. Exposure to childhood adversity and deficits in emotion recognition: results from a large, population-based sample
  102. Is smoking heaviness causally associated with alcohol use? A Mendelian randomization study in four European cohorts
  103. Association of Combined Patterns of Tobacco and Cannabis Use in Adolescence With Psychotic Experiences
  104. Genetics of biologically based psychological differences
  105. The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records
  106. Corrigendum: Alcohol Use in Adolescence and Later Working Memory: Findings From a Large Population-Based Birth Cohort
  107. State anxiety and information processing: A 7.5% carbon dioxide challenge study
  108. Biased Estimates in Mendelian Randomization Studies Conducted in Unrepresentative Samples
  109. Robust research needs many lines of evidence
  110. StopWatch: The preliminary evaluation of a smartwatch-based system for passive detection of cigarette smoking
  111. Alcohol Use in Adolescence and Later Working Memory: Findings From a Large Population-Based Birth Cohort
  112. Associations of genetic determinants of serum vitamin B12 and folate concentrations with hay fever and asthma: a Mendelian randomization meta-analysis
  113. Cognitive bias modification for facial interpretation: a randomized controlled trial of transfer to self-report and cognitive measures in a healthy sample
  114. Smoking status and attractiveness among exemplar and prototypical identical twins discordant for smoking
  115. Genome-Wide Association Studies of a Broad Spectrum of Antisocial Behavior
  116. Perceiving the evil eye: Investigating hostile interpretation of ambiguous facial emotional expression in violent and non-violent offenders
  117. Evaluating clinical stop-smoking services globally: towards a minimum data set
  118. Attrition from Web-Based Cognitive Testing: A Repeated Measures Comparison of Gamification Techniques
  119. Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization
  120. Impact of variation in functions and delivery on the effectiveness of behavioural and mood management interventions for smoking cessation in people with depression: protocol for a systematic review and meta-analysis
  121. Longitudinal associations of social cognition and substance use in childhood and early adolescence: findings from the Avon Longitudinal Study of Parents and Children
  122. Maternal Smoking in Pregnancy and Offspring Depression: a cross cohort and negative control study
  123. Associations of coffee genetic risk scores with consumption of coffee, tea and other beverages in the UK Biobank
  124. Collider scope: when selection bias can substantially influence observed associations
  125. Logical and Methodological Issues Affecting Genetic Studies of Humans Reported in Top Neuroscience Journals
  126. No Impact of Calorie or Unit Information on Ad Libitum Alcohol Consumption
  127. Redefine statistical significance
  128. Body mass index, body dissatisfaction and adolescent smoking initiation
  129. Heavier smoking increases coffee consumption: findings from a Mendelian randomization analysis
  130. Drinking status but not acute alcohol consumption influences delay discounting
  131. Estimating the causal effect of body mass index on hay fever, asthma and lung function using Mendelian randomization
  132. Resisting the urge to smoke: inhibitory control training in cigarette smokers
  133. Cognitive bias modification of face emotion perception: A randomised controlled trial of transference to cognitive and self-report measures in healthy volunteers
  134. Does coffee consumption impact on heaviness of smoking?
  135. The Burden of the “False‐Negatives” in Clinical Development: Analyses of Current and Alternative Scenarios and Corrective Measures
  136. The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records
  137. Genome-wide association study of facial emotion recognition in children and association with polygenic risk for mental health disorders
  138. Patterns of cannabis use during adolescence and their association with harmful substance use behaviour: findings from a UK birth cohort
  139. Biased Facial-Emotion Perception in Mental Health Disorders: A Possible Target for Psychological Intervention?
  140. How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis
  141. Promoting reproducibility in addiction research
  142. Investigating the causal effect of smoking on hay fever and asthma: a Mendelian randomization meta-analysis in the CARTA consortium
  143. Digital phenotyping and the development and delivery of health guidelines and behaviour change interventions
  144. State anxiety and emotional face recognition in healthy volunteers
  145. How to compare instrumental variable and conventional regression analyses using negative controls and bias plots
  146. Improving the Efficiency of Grant and Journal Peer Review: Registered Reports Funding
  147. Variation in the recall of socially rewarding information and depressive symptom severity: a prospective cohort study
  148. Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression
  149. Impaired Recognition of Basic Emotions from Facial Expressions in Young People with Autism Spectrum Disorder: Assessing the Importance of Expression Intensity
  150. Substance use, criminal behaviour and psychiatric symptoms following childhood traumatic brain injury: findings from the ALSPAC cohort
  151. Genetic Overlap Between Schizophrenia and Developmental Psychopathology: Longitudinal and Multivariate Polygenic Risk Prediction of Common Psychiatric Traits During Development
  152. Prefrontal cortex stimulation does not affect emotional bias, but may slow emotion identification
  153. Low statistical power in biomedical science: a review of three human research domains
  154. The Morphed Photographic Figure Scale: Creation and validation of a novel set of realistic female body stimuli
  155. Investigating causality in associations between smoking initiation and schizophrenia using Mendelian randomization
  156. Scanning the horizon: towards transparent and reproducible neuroimaging research
  157. Neural mechanisms underlying visual attention to health warnings on branded and plain cigarette packs
  158. Childhood Traumatic Brain Injury and the Associations With Risk Behavior in Adolescence and Young Adulthood
  159. Commentary: Delay discounting and smoking: robust correlation, but uncertain causation
  160. Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study
  161. The CHRNA5–A3–B4 Gene Cluster and Smoking: From Discovery to Therapeutics
  162. The efficacy of fish oil supplements in the treatment of depression: food for thought
  163. Current Incentives for Scientists Lead to Underpowered Studies with Erroneous Conclusions
  164. An interactive training programme to treat body image disturbance
  165. Association of a Genetic Risk Score With Body Mass Index
  166. Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis
  167. Effect of glass markings on drinking rate in social alcohol drinkers
  168. Gamification for health promotion: systematic review of behaviour change techniques in smartphone apps
  169. Letter to the Editor: Moving science forward by increasing awareness of reporting and citation biases: a reply to Vrshek-Schallhorn et al. (2016)
  170. Citation bias and selective focus on positive findings in the literature on the serotonin transporter gene (5-HTTLPR), life stress and depression
  171. Behavioural tasks sensitive to acute abstinence and predictive of smoking cessation success: a systematic review and meta-analysis
  172. A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort
  173. Joint developmental trajectories of internalizing and externalizing disorders between childhood and adolescence
  174. Gamification of Cognitive Assessment and Cognitive Training: A Systematic Review of Applications and Efficacy
  175. Acute anxiety and social inference: An experimental manipulation with 7.5% carbon dioxide inhalation
  176. Variation in health warning effectiveness on cigarette packs: a need for regulation?
  177. The effects of gamelike features and test location on cognitive test performance and participant enjoyment
  178. Null is beautiful: On the importance of publishing null results
  179. Replication Validity of Initial Association Studies: A Comparison between Psychiatry, Neurology and Four Somatic Diseases
  180. Scanning the Horizon: Future challenges for neuroimaging research
  181. Does wine glass size influence sales for on-site consumption? A multiple treatment reversal design
  182. Open Science and Research Reproducibility
  183. Triangulating meta-analyses: the example of the serotonin transporter gene, stressful life events and major depression
  184. Understanding the Role of Additives in Tobacco Products
  185. Investigating causality in the association between 25(OH)D and schizophrenia
  186. The Association of Cigarette Smoking With Depression and Anxiety: A Systematic Review
  187. Dynamic Dazzle Distorts Speed Perception
  188. Genetic Relationship between Schizophrenia and Nicotine Dependence
  189. Snus use and risk of schizophrenia and non-affective psychosis
  190. Psychotic Experiences and Working Memory: A Population-Based Study Using Signal-Detection Analysis
  191. Tobacco Marketing by Stealth
  192. Emotion recognition training using composite faces generalises across identities but not all emotions
  193. Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture
  194. Neural correlates of cigarette health warning avoidance among smokers
  195. Smoking and caffeine consumption: a genetic analysis of their association
  196. Associations between smoking and caffeine consumption in two European cohorts
  197. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
  198. Response to Comment on "Estimating the reproducibility of psychological science"
  199. Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium
  200. Pain-related and Psychological Symptoms in Adolescents With Musculoskeletal and Sleep Problems
  201. EMOTICOM: A Neuropsychological Test Battery to Evaluate Emotion, Motivation, Impulsivity, and Social Cognition
  202. Navigating conflicts of interest in a rapidly changing research landscape
  203. How Can Technology Support Smoking Cessation Interventions?
  204. Conflicts of Interest and Solicited Replication Attempts
  205. G = E: What GWAS Can Tell Us about the Environment
  206. Navigating an open road
  207. Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2
  208. An Open Pilot Study of Training Hostile Interpretation Bias to Treat Disruptive Mood Dysregulation Disorder
  209. Prospective Investigation of Video Game Use in Children and Subsequent Conduct Disorder and Depression Using Data from the Avon Longitudinal Study of Parents and Children
  210. Effects of the pattern of glucocorticoid replacement on neural processing, emotional reactivity and well-being in healthy male individuals: study protocol for a randomised controlled trial
  211. Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
  212. Causal Inference in Developmental Origins of Health and Disease (DOHaD) Research
  213. Exploring the associations shared by mood, pain-related attention and pain outcomes related to sleep disturbance in a chronic pain sample
  214. Association between smoking-related attentional bias and craving measured in the clinic and in the natural environment.
  215. The effects of e-cigarette visual appearance on craving and withdrawal symptoms in abstinent smokers.
  216. Does Glass Size and Shape Influence Judgements of the Volume of Wine?
  217. Feedback training induces a bias for detecting happiness or fear in facial expressions that generalises to a novel task
  218. Cardiovascular and neuropsychiatric risks of varenicline: too good to be true?
  219. Smoking and diabetes risk: building a causal case with clinical implications
  220. Anxiety sensitivity and trait anxiety are associated with response to 7.5% carbon dioxide challenge
  221. Effect of Smoking on Blood Pressure and Resting Heart RateCLINICAL PERSPECTIVE
  222. What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study
  223. Opening up addiction science
  224. Using prediction markets to forecast research evaluations
  225. Citation Distortions in the Literature on the Serotonin-Transporter-Linked Polymorphic Region and Amygdala Activation
  226. Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts
  227. Smoking as a causal risk factor for schizophrenia
  228. Personality and smoking: individual-participant meta-analysis of nine cohort studies
  229. Possible Association of APOE Genotype with Working Memory in Young Adults
  230. Association of Alcohol Consumption with Perception of Attractiveness in a Naturalistic Environment
  231. Changing mothers’ perception of infant emotion: a pilot study
  232. Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium: Table 1
  233. Effects of 7.5% carbon dioxide (CO2) inhalation and ethnicity on face memory
  234. The effect of glass shape on alcohol consumption in a naturalistic setting: a feasibility study
  235. Guidelines on Statistical Reporting at Nicotine & Tobacco Research
  236. Smoking and diabetes: strengthening causal inference
  237. The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt
  238. No Own-Age Advantage in Children’s Recognition of Emotion on Prototypical Faces of Different Ages
  239. Does smoking reduction worsen mental health? A comparison of two observational approaches
  240. The Developmental Relationship Between Depressive Symptoms in Adolescence and Harmful Drinking in Emerging Adulthood: The Role of Peers and Parents
  241. Effect of the rs1051730–rs16969968 variant and smoking cessation treatment: a meta-analysis
  242. Cannabis and psychosis
  243. Associations of Cannabis and Cigarette Use with Depression and Anxiety at Age 18: Findings from the Avon Longitudinal Study of Parents and Children
  244. Understanding the candidate gene × environment interaction debate: epistemological or evidential divide?
  245. Fear of Negative Evaluation Biases Social Evaluation Inference: Evidence from a Probabilistic Learning Task
  246. Using molecular genetic information to infer causality in observational data: Mendelian randomisation
  247. Evaluating psychological interventions in a novel experimental human model of anxiety
  248. Lack of attentional retraining effects in cigarette smokers attempting cessation: A proof of concept double-blind randomised controlled trial
  249. Effects of first exposure to plain cigarette packaging on smoking behaviour and attitudes: a randomised controlled study
  250. Early effects of duloxetine on emotion recognition in healthy volunteers
  251. Recent Innovations at Nicotine & Tobacco Research
  252. Distinct Neuropsychological Mechanisms May Explain Delayed- Versus Rapid-Onset Antidepressant Efficacy
  253. Why Is There a Link Between Smoking and Suicide?
  254. Increased Facial Attractiveness Following Moderate, but not High, Alcohol Consumption
  255. Adolescent cannabis and tobacco use and educational outcomes at age 16: birth cohort study
  256. The Mediating Role of Deviant Peers on the Link Between Depressed Mood and Harmful Drinking
  257. Rethinking the association between smoking and schizophrenia
  258. Importance of national context in the translation of personalised treatments for smoking cessation
  259. A New Editor-in-Chief for Nicotine & Tobacco Research
  260. Genetics of Smoking Behaviour
  261. Latent Trajectory Classes for Alcohol-Related Blackouts from Age 15 to 19 in ALSPAC
  262. Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers
  263. Stratification by Smoking Status Reveals an Association of CHRNA5-A3-B4 Genotype with Body Mass Index in Never Smokers
  264. Assessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease
  265. Meta-Analysis of Emotion Recognition in Depression
  266. The genetic architecture of psychophysiological phenotypes
  267. Effects of Nicotine and Nicotine Expectancy on Attentional Bias for Emotional Stimuli
  268. Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study
  269. Re: "Exposure to Maternal Smoking During Pregnancy as a Risk Factor for Tobacco use in Adult Offspring"
  270. Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium
  271. Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction
  272. Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypes
  273. Scientific rigor and the art of motorcycle maintenance
  274. Determining the Causes and Consequences of Nicotine Dependence: Emerging Genetic Research Methods
  275. The association between depressive symptoms from early to late adolescence and later use and harmful use of alcohol
  276. Commentary: Does mortality from smoking have implications for future Mendelian randomization studies?
  277. "Pictures Don't Lie, Seeing Is Believing": Exploring Attitudes to the Introduction of Pictorial Warnings on Cigarette Packs in Ghana
  278. Commentary: Response to commentary by Rutter on Munafo et al. (2014)
  279. Genetics: Finding Genes for Schizophrenia
  280. Extinction of cue-evoked drug-seeking relies on degrading hierarchical instrumental expectancies
  281. Phenotype Refinement Strengthens the Association of AHR and CYP1A1 Genotype with Caffeine Consumption
  282. Is there an excess of significant findings in published studies of psychotherapy for depression?
  283. Schizophrenia: Genesis of a complex disease
  284. Significance chasing in research practice: causes, consequences and possible solutions
  285. Has analytical flexibility increased in imaging studies of bipolar disorder and major depression?
  286. Plain packaging of cigarettes and smoking behavior: study protocol for a randomized controlled study
  287. Effects of acute alcohol consumption and processing of emotion in faces: Implications for understanding alcohol-related aggression
  288. Partner smoking and maternal cotinine during pregnancy: Implications for negative control methods
  289. Practitioner Review: A critical perspective on gene–environment interaction models – what impact should they have on clinical perceptions and practice?
  290. Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention
  291. Article Commentary: On the Persistence of Low Power in Psychological Science
  292. Common or Rare Variants for Complex Traits?
  293. Effects of 7.5% carbon dioxide inhalation on anxiety and mood in cigarette smokers
  294. Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children
  295. Registered Reports: A new submission format at Drug and Alcohol Dependence
  296. Maternal smoking during pregnancy and offspring smoking initiation: assessing the role of intrauterine exposure
  297. Avoidance of cigarette pack health warnings among regular cigarette smokers
  298. Mendelian randomization in health research: Using appropriate genetic variants and avoiding biased estimates
  299. Incentivising reproducible research
  300. For the Love of the Game: Implicit Arousal Following Symbolic Destruction of Sports Teams and Partners
  301. Ian Robertson
  302. Nicotine patch preloading for smoking cessation (the preloading trial): study protocol for a randomized controlled trial
  303. A recall-by-genotype study of CHRNA5-A3-B4 genotype, cotinine and smoking topography: study protocol
  304. Modelling the effects of subjective and objective decision making in scientific peer review
  305. The effects of food-related attentional bias training on appetite and food intake
  306. Outcomes of childhood conduct problem trajectories in early adulthood: findings from the ALSPAC study
  307. Social anxiety is associated with general but not specific biases in emotion recognition
  308. Effects of 7.5% CO2-Induced Anxiety on Individual Performance During a Group Computer Combat Game
  309. Conduct problem trajectories and alcohol use and misuse in mid to late adolescence
  310. Mining the Human Phenome Using Allelic Scores That Index Biological Intermediates
  311. Empirical evidence for low reproducibility indicates low pre-study odds
  312. Are waterpipe users tobacco-dependent?
  313. Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatment
  314. Improving the reliability and reporting of genetic association studies
  315. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion
  316. Ablating Adult Neurogenesis in the Rat Has No Effect on Spatial Processing: Evidence from a Novel Pharmacogenetic Model
  317. Lack of association of DRD4 exon 3 VNTR genotype with reactivity to dynamic smoking cues in movies
  318. Synthesis of evidence on heterogeneous interventions with multiple outcomes recorded over multiple follow-up times reported inconsistently: a smoking cessation case-study
  319. Lack of association between DRD2 and OPRM1 genotypes and adiposity
  320. A genomewide association study of smoking relapse in four European population-based samples
  321. Potential Reporting Bias in fMRI Studies of the Brain
  322. Association of Maternal Smoking With Child Cotinine Levels
  323. Childhood conduct disorder trajectories, prior risk factors and cannabis use at age 16: birth cohort study
  324. USING MENDELIAN RANDOMISATION TO INFER CAUSALITY IN DEPRESSION AND ANXIETY RESEARCH
  325. Confidence and precision increase with high statistical power
  326. Herit-Ability
  327. Acute Anxiety Impairs Accuracy in Identifying Photographed Faces
  328. Effects of Acute Anxiety Induction on Speech Perception
  329. Will peak provoked craving prove superior to cue-reactivity?
  330. Methods reporting in human laboratory studies
  331. Power failure: why small sample size undermines the reliability of neuroscience
  332. Increasing Recognition of Happiness in Ambiguous Facial Expressions Reduces Anger and Aggressive Behavior
  333. A Translational Rodent Assay of Affective Biases in Depression and Antidepressant Therapy
  334. Using Alzgene-Like Approaches to Investigate Susceptibility Genes for Vascular Cognitive Impairment
  335. Candidate and non-candidate genes in behavior genetics
  336. Acutely induced anxiety increases negative interpretations of events in a closed-circuit television monitoring task
  337. Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects
  338. Lack of Association Between COMT and Working Memory in a Population-Based Cohort of Healthy Young Adults
  339. Deep impact: unintended consequences of journal rank
  340. Tobacco
  341. Slimming World in Stop Smoking Services (SWISSS): study protocol for a randomized controlled trial
  342. Protocol for a collaborative meta-analysis of 5-HTTLPR, stress, and depression
  343. Measuring hand preference: A comparison among different response formats using a selected sample
  344. Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial
  345. Effects of alcohol on disinhibition towards alcohol-related cues
  346. Attentional bias retraining in cigarette smokers attempting smoking cessation (ARTS): Study protocol for a double blind randomised controlled trial
  347. Cue Reactivity
  348. Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task
  349. Social inference and social anxiety: Evidence of a fear-congruent self-referential learning bias
  350. Testing times
  351. An Open, Large-Scale, Collaborative Effort to Estimate the Reproducibility of Psychological Science
  352. THE SEROTONIN TRANSPORTER GENE AND DEPRESSION
  353. Visual attention to health warnings on plain tobacco packaging in adolescent smokers and non-smokers
  354. Reducing harm from tobacco use
  355. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
  356. Lack of Association of OPRM1 Genotype and Smoking Cessation
  357. Pharmacogenetic Smoking Cessation Intervention in a Health Care Setting: A Pilot Feasibility Study
  358. Pathways Between Childhood Victimization and Psychosis-like Symptoms in the ALSPAC Birth Cohort
  359. Electrophysiological indices of biased cognitive processing of substance-related cues: A meta-analysis
  360. Effects of acute nicotine and alcohol on the rating of attractiveness in social smokers and alcohol drinkers
  361. Glass Shape Influences Consumption Rate for Alcoholic Beverages
  362. Gender inequality in awarded research grants
  363. Methodological considerations in cognitive bias research: The next steps
  364. Understanding emotion: Lessons from anxiety
  365. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
  366. Interventions for smoking cessation in hospitalised patients
  367. Acute alcohol impairs human goal-directed action
  368. From Men to Mice: CHRNA5/CHRNA3, Smoking Behavior and Disease
  369. Effects of emotion perception training on mood in undergraduate students: randomised controlled trial
  370. Association Between Genetic Variants on Chromosome 15q25 Locus and Objective Measures of Tobacco Exposure
  371. Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior
  372. Effect on Adherence to Nicotine Replacement Therapy of Informing Smokers Their Dose Is Determined by Their Genotype: A Randomised Controlled Trial
  373. The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a meta-analysis
  374. Inhalation of 7.5% carbon dioxide increases alerting and orienting attention network function
  375. Dopamine and food reward: Effects of acute tyrosine/phenylalanine depletion on appetite
  376. The relationship between childhood depressive symptoms and problem alcohol use in early adolescence: findings from a large longitudinal population-based study
  377. Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers
  378. Internal reliability of measures of substance-related cognitive bias
  379. Patterns of Alcohol Use in Early Adolescence Predict Problem Use at Age 16
  380. Technical, Ethical and Social Issues in the Bioprediction of Addiction Liability and Treatment Response
  381. Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses
  382. Bite-Size Science and Its Undesired Side Effects
  383. Evaluation of a novel translational task for assessing emotional biases in different species
  384. Effects of caffeine on alcohol-related changes in behavioural control and perceived intoxication in light caffeine consumers
  385. Association Between Nicotinic Acetylcholine Receptor Single Nucleotide Polymorphisms and Smoking Cessation
  386. Socioeconomic status and smoking: a review
  387. Association of the CHRNA5-A3-B4 Gene Cluster With Heaviness of Smoking: A Meta-Analysis
  388. Characterizing Patterns of Smoking Initiation in Adolescence: Comparison of Methods for Dealing With Missing Data
  389. Association of study characteristics with estimates of effect size in studies of ecstasy use
  390. The effects of 7.5% carbon dioxide inhalation on task performance in healthy volunteers
  391. Dissecting the genetic architecture of human personality
  392. Smoking Is Associated with, but Does Not Cause, Depressed Mood in Pregnancy – A Mendelian Randomization Study
  393. Structural Neuroimaging Studies in Major Depressive Disorder
  394. Effects of acute alcohol consumption on alcohol-related cognitive biases in light and heavy drinkers are task-dependent
  395. CHRNA3 rs1051730 Genotype and Short-Term Smoking Cessation
  396. Effects of 7.5% CO2inhalation on allocation of spatial attention to facial cues of emotional expression
  397. Weight Change Over Eight Years in Relation to Alcohol Consumption in a Cohort of Continuing Smokers and Quitters
  398. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index
  399. Reply to: With Great Power Comes Great Responsibility: Meta-Analytic Proof for a Timeless Insight
  400. Inhalation of 7.5% Carbon Dioxide Increases Threat Processing in Humans
  401. Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia
  402. Plain packaging increases visual attention to health warnings on cigarette packs in non-smokers and weekly smokers but not daily smokers
  403. Stability of Autistic Traits in the General Population: Further Evidence for a Continuum of Impairment
  404. Epidemiology of Tobacco Use
  405. Delayed reward discounting and addictive behavior: a meta-analysis
  406. A pilot study of the effectiveness of d-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects
  407. Pharmacogenetics of Smoking Cessation in General Practice: Results From the Patch II and Patch in Practice Trials
  408. Effect of social stress during acute nicotine abstinence
  409. The influence of tobacco consumption on the relationship between schizotypy and hemispheric asymmetry
  410. Association of COMT Val108/158Met Genotype and Cigarette Smoking in Pregnant Women
  411. Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence
  412. INDUSTRY FUNDING AND PLACEBO QUIT RATE IN CLINICAL TRIALS OF NICOTINE REPLACEMENT THERAPY: A COMMENTARY ON ETTER ET AL. (2007)
  413. Breaking Barriers in the Genomics and Pharmacogenetics of Drug Addiction
  414. Effects of acute alcohol consumption on the perception of eye gaze direction
  415. Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers
  416. How reliable are scientific studies?
  417. WHAT'S THE MATTER WITH CUE-INDUCED CRAVING? A COMMENTARY ON PERKINS
  418. Is the UK's coalition Government serious about public health?
  419. Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation
  420. Erratum
  421. Cigarette smoking and depression: a question of causation
  422. Association of the 5- HTTLPR genotype and unipolar depression: a meta-analysis
  423. Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement
  424. Defining Replication: A Response to Kaufman and Colleagues
  425. Sex and location as determinants of handedness: Reply to Vuoksimaa and Kaprio (2010).
  426. Human development
  427. Reliability and replicability of genetic association studies
  428. Association of genes coding for the α-4, α-5, β-2 and β-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence
  429. Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls
  430. Genetic and non-genetic influences on the development of co-occurring alcohol problem use and internalizing symptomatology in adolescence: a review
  431. Replication and heterogeneity in gene×environment interaction studies
  432. Smoking status and body mass index: A longitudinal study
  433. Effects of acute abstinence and nicotine administration on taste perception in cigarette smokers
  434. Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
  435. Gene × Environment Interactions at the Serotonin Transporter Locus
  436. Bias in genetic association studies and impact factor
  437. Effects of alcohol consumption and alcohol expectancy on the categorisation of perceptual cues of emotional expression
  438. Association of the DRD2 gene Taq1A polymorphism and smoking behavior: A meta-analysis and new data
  439. Reply
  440. [Commentary] THE CLINICAL UTILITY OF GENETIC TESTS
  441. Effects of acute nicotine administration on ratings of attractiveness of facial cues
  442. A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse.
  443. Attentional bias training and cue reactivity in cigarette smokers
  444. Smoking patterns during pregnancy and postnatal period and depressive symptoms
  445. Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: New data from the Patch in Practice trial and pooled analyses
  446. Smoking Cessation Interventions for Hospitalized Smokers
  447. Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues
  448. Sex differences in left-handedness: A meta-analysis of 144 studies.
  449. Genetic variation in the dopamine pathway and smoking cessation
  450. Using genetic data in cognitive neuroscience: from growing pains to genuine insights
  451. Research Highlights
  452. Letter to the Editor: Bias in genetic association studies: effects of research location and resources
  453. Meta-Analysis of the Cognitive Effects of the Catechol-O-Methyltransferase Gene Val158/108Met Polymorphism
  454. Forum: interactions between gene and environment
  455. Effects of acute alcohol consumption and alcohol expectancy on processing of perceptual cues of emotional expression
  456. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study
  457. 5‐HTTLPR genotype and anxiety‐related personality traits: A meta‐analysis and new data
  458. Genes and cigarette smoking
  459. Smoking cessation in primary care
  460. Effects of acute alcohol consumption on processing of perceptual cues of emotional expression
  461. Serotonin Transporter (5-HTTLPR) Genotype and Amygdala Activation: A Meta-Analysis
  462. "Intention to Analyze" in Pharmacogenomics Studies
  463. Association of COMT Val108/158Met genotype with smoking cessation
  464. Effects of progression to cigarette smoking on depressed mood in adolescents: evidence from the National Longitudinal Study of Adolescent Health
  465. Effects of Acute Alcohol Consumption on Ratings of Attractiveness of Facial Stimuli: Evidence of Long-Term Encoding
  466. Association of the Dopamine D4 Receptor (DRD4) Gene and Approach-Related Personality Traits: Meta-Analysis and New Data
  467. A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation
  468. Genetics and Smoking Cessation
  469. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials
  470. Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers
  471. Effects of acute tyrosine depletion on subjective craving and selective processing of smoking-related cues in abstinent cigarette smokers
  472. Neuregulin 1 Genotype and Schizophrenia
  473. Adolescent Environmental Tobacco Smoke Exposure Predicts Academic Achievement Test Failure
  474. Weekly versus basic smoking cessation support in primary care: a randomised controlled trial
  475. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation
  476. Interventions for smoking cessation in hospitalised patients
  477. Association of COMT Val108/158Met Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial
  478. Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study
  479. Effects of dopamine D2 receptor gene polymorphisms on smoking cessation: abstinence and withdrawal symptoms
  480. Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch
  481. Effect of tryptophan depletion on the attentional salience of smoking cues
  482. Association of the mu-opioid receptor gene with smoking cessation
  483. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case–control studies and evidence of publication bias
  484. Neuroticism Response to Stress, Genetic Mapping of Mice
  485. The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial
  486. Personality and smoking status: A meta-analysis
  487. Personality and smoking status: A longitudinal analysis
  488. Can pharmacogenetics help smokers quit?
  489. The endophenotype concept in psychiatric genetics
  490. Selective Processing of Gastrointestinal Symptom-related Stimuli in Irritable Bowel Syndrome
  491. Maternal smoking during late pregnancy and offspring smoking behaviour
  492. Smoking cessation, weight gain, andDRD4 −521 genotype
  493. Association of the NRG1 gene and schizophrenia: a meta-analysis
  494. Lack of Association of 5-HTTLPR Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial
  495. Candidate gene studies in the 21st century: meta-analysis, mediation, moderation
  496. Psychiatric patients and gene-based smoking cessation packages
  497. Neuroticism Mediates the Association of the Serotonin Transporter Gene with Lifetime Major Depression
  498. Early morning salivary cortisol is not associated with extraversion
  499. Selective processing of social threat cues following acute tryptophan depletion
  500. Longitudinal analysis of the effect of prenatal nicotine exposure on subsequent smoking behavior of offspring
  501. Association of the dopamine-β-hydroxylase gene with nicotine dependence: No evidence for mediation by personality
  502. Association of serotonin transporter genotype with selective processing of smoking‐related stimuli in current smokers and ex‐smokers
  503. Harm reduction: lessons learned from tobacco control
  504. Ventral Striatum/Nucleus Accumbens Activation to Smoking-Related Pictorial Cues in Smokers and Nonsmokers: A Functional Magnetic Resonance Imaging Study
  505. The Serotonin Transporter Length Polymorphism, Neuroticism, and Depression: A Comprehensive Assessment of Association
  506. Measurement scale does moderate the association between the serotonin transporter gene and trait anxiety: comments on Munafo et al
  507. Promise and pitfalls in the meta-analysis of genetic association studies: a response to Sen and Schinka
  508. Integrating genetic, behavioral, and psychometric research in conceptualizing human behavioral traits
  509. Conventional P-values fail to assure reproducibility for genetic association tests
  510. Response to Manly: Statistical stringency in tests of genetic association – implications for sample size and study design
  511. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case–control studies
  512. Pharmacogenetics and nicotine addiction treatment
  513. A Functional Genetic Variation of the Serotonin (5-HT) Transporter Affects 5-HT1A Receptor Binding in Humans
  514. Association of serotonin transporter gene polymorphism with nicotine dependence: no evidence for an interaction with trait neuroticism
  515. Association between the serotonin transporter gene and alcohol consumption in social drinkers
  516. A family smoking index to capture genetic influence in smoking: Rationale and two validation studies
  517. Association between the DRD2 gene Taq1A (C32806T) polymorphism and alcohol consumption in social drinkers
  518. P.6.042 Association between the serotonin transporter gene and alcohol consumption in social drinkers: evidence for mediation by anxiety-related personality
  519. Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis
  520. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis
  521. Investigating subgroups in smoking cessation treatment response: Response to Perkins
  522. Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis
  523. Meta-analysis of genetic association studies
  524. The genetic basis for smoking behavior: A systematic review and meta-analysis
  525. Are there sex differences in the association between the 5HTT gene and neuroticism? A meta-analysis
  526. Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial
  527. Replication validity of genetic association studies of smoking behavior: What can meta-analytic techniques offer?
  528. Selective processing of threat-related cues in day surgery patients and prediction of post-operative pain
  529. Selective Processing of Smoking-Related Cues in Current Smokers, Ex-Smokers and Never-Smokers on the Modified Stroop Task
  530. Pharmacological therapy is relatively cost-effective when added to smoking cessation counselling
  531. Genetic Polymorphisms and Personality in Healthy Adults: A systematic review and meta-analysis
  532. Interventions for smoking cessation in hospitalised patients
  533. Bromocriptine use is associated with decreased smoking rates
  534. Anxiety and surgical recovery
  535. Interventions for smoking cessation in hospitalised patients: a systematic review
  536. New directions in the genetic mechanisms underlying nicotine addiction
  537. Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy
  538. Perioperative anxiety and postoperative pain
  539. Associative learning and pain? Why stop there?
  540. Pharmacogenomics of Tobacco Addiction